• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Europe Diabetes Pen Market

    ID: MRFR/MED/0171-HCR
    105 Pages
    Kinjoll Dey
    October 2025

    Europe, the Middle East and Africa Diabetes Pen Market- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Europe Diabetes Pen Market Infographic
    Purchase Options

    Europe Diabetes Pen Market Summary

    The Europe, the Middle East and Africa Diabetes Pen market is projected to grow significantly from 18.47 USD Billion in 2024 to 47.19 USD Billion by 2035.

    Key Market Trends & Highlights

    Europe, the Middle East and Africa Diabetes Pen Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 8.9 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 47.2 USD Billion, indicating robust growth potential.
    • in 2024, the market is valued at 18.47 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of diabetes management technologies due to increasing prevalence of diabetes is a major market driver.

    Market Size & Forecast

    2024 Market Size 18.47 (USD Billion)
    2035 Market Size 47.19 (USD Billion)
    CAGR (2025-2035) 8.90%

    Major Players

    Becton, Dickinson And Company, Novo Nordisk A/S, Ypsomed Holding Ag, Owen Mumford. Ltd, Sanofi, Eli Lilly, Merck Animal Health

    Europe Diabetes Pen Market Trends

    Technological Advancements in the Industry to Drive the Market Growth

    To regulate insulin, diabetic patients use an insulin pen or injection pen. It is a simple and convenient method for administering insulin via injection. It eliminates the need to hold the vial and syringe, allowing patients to administer insulin in the workplace or at school for their children. It requires significantly less time than syringes. There are two types of insulin syringes on the market: disposable and reusable. Diabetes pen improves quality of life and decreases hyperglycemia-related anxiety. Diabetes is becoming more prevalent, which has increased the demand for Diabetes pens.

    Diabetes pens are administered concurrently with the growing demand for insulin pens among diabetics. These devices used in conjunction with insulin syringes aid in administering the medication to the subject. Massive technological advancements also contribute to the expansion of the Diabetes pen market.

    Consumer Preference for Insulin Pens as Drug Delivery System

    Increasing use of innovative, reusable injection devices by diabetic patients is a further factor propelling the market forward. In addition, the growing prevalence of automated injection pens is a significant factor in the market expansion of injection pens. Due to their simplicity of use, precision, safety, and convenience in medication delivery, automated injection instruments are increasingly utilized by medical personnel. Injection pens are in high demand all over the world, not just in affluent nations where the geriatric population is at an increased risk for diseases such as diabetes and cancer.

    These elements are responsible for the expansion of the market.

    Diabetes pens should not be shared due to the risk of disease transmission, including hepatitis B. Diabetes pen needles with reduced lengths can be used with ease by all patients, including those who are overweight. These factors have positively anticipated propelling the development of the Europe, the Middle East and Africa Diabetes Pen Market.

    However, there are certain constraints and limitations that will impede the expansion of the Europe, the Middle East and Africa Diabetes Pen Market as a whole. Two types of insulin cannot be mixed in an insulin pen, thereby increasing the required injection frequency, which, in turn, inhibits the market's growth.

    Market Segment Insights

    Europe, the Middle East and Africa Diabetes Pen Type Insights

    The market, based on type, has been bifurcated into Disposable insulin pen, and reusable insulin pen. The reusable variable has the highest CAGR as a result of the rising demand for diabetic patients and the growing awareness of self-administration of insulin. The affordability of reusable insulins also contributes to the market expansion.

    EME and Africa Diabetes Pen Therapy Insights

    The market, based on type, has been segmented into Insulin, Glucagon-Like Peptide-1 (Glp-1), Growth Hormones.

    Get more detailed insights about Europe Diabetes Pen Market– Forecast to 2034

    Regional Insights

    The market, based on region, has been focused on Europe, and Middle East and Africa regions.

    Europe is the largest market in the world and is anticipated to experience negligible expansion over the forecast period. This article attributes the development of the region to the widespread use of diabetes pens in the United Kingdom. In addition, the implementation of aggressive market penetration strategies by major market participants is anticipated to result in a rise in insulin pen adoption in the region over the forecast period.

    Due to rising consumer awareness of lifestyle-related diseases and the emergence of an inundation of preventative measures to combat the elevated sugar levels of individuals, the Middle East and Africa region is anticipated to experience constant and respectable growth. Due to the high prevalence of obese and overweight citizens, the incidence of diabetes in Saudi Arabia is rising significantly and is anticipated to remain high in the coming years. Iran, the second-largest country in the Middle East, has a significant diabetes problem due to its high prevalence rate, rising incidence rate, and economic impact.

    In Iran, diabetes-related mortality continues to rise; the age-adjusted fatality rate from diabetes has increased over time. Diabetes has significant economic ramifications for the nation. In addition to its high direct healthcare expenses, diabetes is a major risk factor for other chronic diseases, such as cardiovascular disease.

    Key Players and Competitive Insights

    As time progresses, the competitive landscape expands as individuals acquire novel and superior products that can generate market value.  The increasing prevalence of diabetes and favorable reimbursement scenario for pen needles, federal initiatives to raise awareness about injection techniques, increasing market penetration by leading players, the development of enhanced pen needle technologies, and ongoing projects will stimulate the market.

    Key Companies in the Europe Diabetes Pen Market market include

    Industry Developments

    July 2023: Injector pens for the low-cost insulins produced by Civica, Inc. was manufactured and supplied by Ypsomed AG beginning in July 2023.  Prior to this announcement, Civica stated that it planned to manufacture three insulin biosimilars: glargine, lispro, and aspart. Both vials and prefilled pens will be made available for purchase. The business hopes to sell the insulins at far lower prices than the competition. Civica will be able to help make self-administered treatment more affordable for Americans with diabetes with the assistance of Ypsomed, a recognized injectable device specialist with over 35 years of experience.

    Future Outlook

    Europe Diabetes Pen Market Future Outlook

    Report Scope

    Attribute/Metric Details
    Market Size 2024   18.47 (USD Billion)
    Market Size 2025   20.11 (USD Billion)
    Market Size 2035 47.19 (USD Billion)
    Compound Annual Growth Rate (CAGR) 8.90% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Type, Therapy & Regional Insights
    Geographies Covered Europe, the Middle East and Africa
    Key Companies Profiled Becton, Dickinson And Company, Novo Nordisk A/S, Ypsomed Holding Ag, Owen Mumford. Ltd, Sanofi, Eli Lilly, Merck Animal Health
    Key Market Opportunities Growing Adoption of Insulin Therapy
    Key Market Dynamics Prevalence of Diabetes, Technological Advancements.

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment
    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials